Insider Buying: Spruce Biosciences, Inc. (NASDAQ:SPRB) Director Buys 200,000 Shares of Stock
Spruce Biosciences, Inc. (NASDAQ:SPRB) Director Bali Muralidhar purchased 200,000 shares of Spruce Biosciences stock in a transaction dated Wednesday, October 14th. The stock was bought at an average price of $15.00 per share, with a total value of $3,000,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of NASDAQ SPRB opened at $15.38 on Friday. Spruce Biosciences, Inc. has a fifty-two week low of $15.12 and a fifty-two week high of $18.49.
Spruce Biosciences Company Profile
Featured Story: How Investors Use a Balance Sheet
Receive News & Ratings for Spruce Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spruce Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.